<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="18319">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01913210</url>
  </required_header>
  <id_info>
    <org_study_id>MetaBPG</org_study_id>
    <nct_id>NCT01913210</nct_id>
  </id_info>
  <brief_title>Effect of Ginseng on Blood Pressure</brief_title>
  <official_title>Effect of Ginseng on Blood Pressure: A Systematic Review and Meta-Analysis of Controlled Trials</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Michael's Hospital, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Michael's Hospital, Toronto</source>
  <oversight_info>
    <authority>Canada: St. Michael's Hospital (Dr. Vladmir Vuksan)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the effect of ginseng on blood pressure control.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The effect of ginseng on blood pressure control is controversial, originating from an early
      1970s observational study, suggesting that ginseng may adversely effect blood pressure.
      Despite these early findings, extensive research has since suggested that ginseng may have a
      positive effect on blood pressure. The current study will help clarify present uncertainty
      on the effect of ginseng on blood pressure control.

      This systematic review and meta-analysis will follow The Cochrane Handbook for Systematic
      Reviews of Interventions. MEDLINE, EMBASE, CINAHL and The Cochrane Central Register of
      Controlled Trials will be searched using appropriate search terms. Intervention trials that
      investigate the effect of ginseng on blood pressure in humans will be included.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">January 2014</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Arterial Pressure</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Blood Pressure</condition>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Ginseng</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Hypertensive Healthy
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical trials in humans

          -  randomized treatment allocation

          -  â‰¥ 1 month

          -  suitable control

          -  viable endpoint data

        Exclusion Criteria:

          -  non-human studies

          -  non-randomized treatment allocation

          -  &lt; 1 month

          -  lack of a suitable control

          -  no viable endpoint data

          -  trials where ginseng is part of a multi-herbal treatment
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vladimir Vuksan, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Michael's Hospital, Toronto</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John Sievenpiper, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Michael's Hospital, Toronto</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Allison Komishon, MSc(c)</last_name>
    <role>Study Director</role>
    <affiliation>St. Michael's Hospital, Toronto</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Toronto 3D Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5C 2T2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 24, 2013</lastchanged_date>
  <firstreceived_date>July 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Michael's Hospital, Toronto</investigator_affiliation>
    <investigator_full_name>Vladimir Vuksan</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
